MCK Q4 2024 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena

MCKMcKesson Corporation

$115B

Q4 2024 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$76.4B+10.8% YoY

Gross Profit

$3.5B4.5% margin

Operating Income

$1.4B1.8% margin

Net Income

$791M1.0% margin

EPS (Diluted)

$6.01

QoQ Revenue Growth

-5.6%

Cash Flow

Operating Cash Flow

$4.1B

Free Cash Flow

$3.9B

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$67.4B

Total Liabilities

$69.0B

Stockholders' Equity

-$2.0B

Cash & Equivalents

$4.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$76.4B	$68.9B	+10.8%
Gross Profit	$3.5B	$3.0B	+16.7%
Operating Income	$1.4B	$1.1B	+24.5%
Net Income	$791M	$787M	+0.5%

Revenue Segments

U.S. Pharmaceutical Segment

$68.8B90%

International Segment

$3.5B5%

Medical-Surgical Solutions Segment

$2.8B4%

Prescription Technology Solutions

$1.2B2%